• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number HGB161007
Device Problems Break (1069); Sticking (1597); Physical Resistance (2578)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/12/2017
Event Type  malfunction  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.(b)(4).The device is going to be sent for analysis.Further information will be provided.
 
Event Description
On (b)(6) 2017, the patient underwent an endovascular procedure using gore® excluder® aaa endoprostheses and gore® excluder® iliac branch endoprostheses (ibe).Reportedly, the physician felt some resistance when attempting to advance an internal iliac component (hgb161007/16176887) through the gore® dryseal flex sheath (dsf1245/1v386846) and the device stuck inside the sheath.After several attempts to push the device, the physician noticed that the device was broken inside the introducer sheath.The physician decided to remove the sheath with the undeployed device and a tip, and use another internal iliac component.The procedure was conducted without any complications.The patient tolerated the procedure.
 
Manufacturer Narrative
On 08/02/2017, the device was sent to gore for analysis.Further information will be provided.
 
Manufacturer Narrative
Updated to indicate the date the engineering evaluation was completed.The device was received by gore on 8/17/2017.The device was sent to gore for analysis.The engineering analysis stated the following: the leading end of the device was broken inside the introducer sheath.The device had deployed inside of the introducer sheath because the deployment line had pulled out of the corset sleeve when the trailing end of the catheter was pulled away from the leading end.The delivery catheter had broken at the trailing olive.The catheter shaft of the delivery catheter was not returned for evaluation.The findings from the evaluation are consistent with the physician¿s observations.The root cause for the catheter breakage could not be determined with the available information.The excluder iliac branch endoprosthesis instructions for use (ifu) clearly states: do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Do not rotate any delivery catheters while the endoprosthesis is inside the introducer sheath.Catheter breakage or premature deployment may occur.Do not rotate the internal iliac component (iic) delivery catheter during delivery, positioning or deployment.Do not attempt to withdraw any undeployed endoprosthesis through the introducer sheaths.The sheath and undeployed device must be removed together.Do not continue advancing and withdrawing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.The excluder iliac branch endoprosthesis instructions for use (ifu) clearly states: do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Do not rotate any delivery catheters while the endoprosthesis is inside the introducer sheath.Catheter breakage or premature deployment may occur.Do not rotate the internal iliac component (iic) delivery catheter during delivery, positioning or deployment.Do not attempt to withdraw any undeployed endoprosthesis through the introducer sheaths.The sheath and undeployed device must be removed together.Do not continue advancing and withdrawing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
nataliya baramzina
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6728599
MDR Text Key80805116
Report Number2953161-2017-00143
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/05/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/05/2020
Device Catalogue NumberHGB161007
Device Lot Number16176887
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient Weight75
-
-